1. Home
  2. AUDC vs ATYR Comparison

AUDC vs ATYR Comparison

Compare AUDC & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AudioCodes Ltd.

AUDC

AudioCodes Ltd.

HOLD

Current Price

$8.71

Market Cap

267.0M

Sector

Utilities

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.85

Market Cap

73.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUDC
ATYR
Founded
1992
2005
Country
Israel
United States
Employees
N/A
58
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
267.0M
73.7M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
AUDC
ATYR
Price
$8.71
$0.85
Analyst Decision
Strong Buy
Hold
Analyst Count
1
9
Target Price
$12.50
$3.67
AVG Volume (30 Days)
85.3K
1.0M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
4.59%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.24
N/A
Revenue Next Year
$2.18
N/A
P/E Ratio
$23.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.95
$0.64
52 Week High
$11.48
$7.29

Technical Indicators

Market Signals
Indicator
AUDC
ATYR
Relative Strength Index (RSI) 62.87 50.25
Support Level $8.55 $0.67
Resistance Level $8.75 $0.85
Average True Range (ATR) 0.25 0.05
MACD 0.02 0.00
Stochastic Oscillator 87.50 66.86

Price Performance

Historical Comparison
AUDC
ATYR

About AUDC AudioCodes Ltd.

AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: